Map

June VOICE is here!

Posted on Jun 03, 2020

In this month's CHR VOICE, we discuss what it means to "follow science" and continue our series on fertility treatments for women with low functional ovarian reserve. Read the June 2020 CHR VOICE here.

Norbert Gleicher, MD, FACOG, FACS

Norbert Gleicher, MD, FACOG, FACS

Norbert Gleicher, MD, leads CHR’s clinical and research efforts as Medical Director and Chief Scientist. A world-renowned specialist in reproductive endocrinology, Dr. Gleicher has published hundreds of peer-reviewed papers and lectured globally while keeping an active clinical career focused on ovarian aging, immunological issues and other difficult cases of infertility.

We have helped women bring over 17,800 babies into the world.

Discover your treatment options

Related Articles

  • Ethical concern with contemporary IVF practiceMillions of people who until only a few decades ago had no chance of genetic parenthood, now have children of their own. Even for professionals in the field, the progress achieved in the understanding of basic physiological processes relating to female and male infertility and basic human embryology over the last few decades, at times, appear futuristic.
  • What is new regarding COVID-19? Most of the COVID-19 news these days is positive: new infections in the U.S. and countries, like Israel, have been declining rapidly and, with its deaths from the disease. At the same time, the news in big parts of the world, especially Europe and Brazil, is not that favorable.
  • PGT-A, costly and unreliable yet marketed vigorously [PR]Dr. Gleicher joins two prominent colleagues in warning against the widespread utilization of PGT-A, in an opinion paper just published
  • IVF Add-Ons: Scientific, Ethical, Regulatory, and Legal ConsiderationsHarvard University's Petrie-Flom Center is hosing a webinar on IVF add-ons on November 10, 2020 at noon EST. Dr. Gleicher

Whats New on CHR

Contact Us

You can also call 212-994-4400 to get in touch with us.

Want to donate your eggs? Fill out the donor application first!

Country *